These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24517434)

  • 41. Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk.
    Coutance G; d'Orio V; Belin L; Bréchot N; Saheb S; Lebreton G; Bouglé A; Rouvier P; Gautreau C; Ouldammar S; Chamillard X; Huot M; Amour J; Combes A; Leprince P; Varnous S
    Transplantation; 2019 Jul; 103(7):1439-1449. PubMed ID: 30376551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
    Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
    J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kidney transplantation across a positive crossmatch: a single-center experience.
    Santos C; Costa R; Malheiro J; Pedroso S; Almeida M; Martins LS; Dias L; Tafulo S; Henriques AC; Cabrita A
    Transplant Proc; 2014; 46(6):1705-9. PubMed ID: 25131017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities.
    Gladstone DE; Bettinotti MP
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):645-650. PubMed ID: 29222316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy.
    Pinelli DF; Zachary AA; Friedewald JJ; Gjertson DW; Evans MA; Chatroop EN; Leffell MS; Vo AA; Jordan SC; Montgomery RA; Tambur AR
    Am J Transplant; 2019 Feb; 19(2):381-390. PubMed ID: 29981209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of donor-specific HLA antibodies in transplantation, a review of the literature published in the last three years.
    Kaneku H
    Clin Transpl; 2010; ():283-306. PubMed ID: 21696047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New Perspectives on Desensitization in the Current Era - An Overview.
    Kumar V; Locke JE
    Front Immunol; 2021; 12():696467. PubMed ID: 34394089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies.
    Akalin E; Dinavahi R; Friedlander R; Ames S; de Boccardo G; Sehgal V; Schröppel B; Bhaskaran M; Lerner S; Fotino M; Murphy B; Bromberg JS
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1160-7. PubMed ID: 18337549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.
    OʼLeary JG; Samaniego M; Barrio MC; Potena L; Zeevi A; Djamali A; Cozzi E
    Transplantation; 2016 Jan; 100(1):39-53. PubMed ID: 26680372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.
    Heidt S; Haasnoot GW; van der Linden-van Oevelen MJH; Claas FHJ
    Front Immunol; 2021; 12():687254. PubMed ID: 34248971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modifiers of complement activation for prevention of antibody-mediated injury to allografts.
    Hughes PD; Cohney SJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):425-33. PubMed ID: 21681097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation.
    Tanabe K; Inui M
    Clin Transplant; 2013; 27 Suppl 26():2-8. PubMed ID: 24299229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
    Kim IK; Choi J; Vo AA; Kang A; Patel M; Toyoda M; Mirocha J; Kamil ES; Cohen JL; Louie S; Galera O; Jordan SC; Puliyanda DP
    Transplantation; 2017 Apr; 101(4):883-889. PubMed ID: 27495773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal transplantation across the donor-specific antibody barrier: Graft outcome and cancer risk after desensitization therapy.
    Yang CY; Lee CY; Yeh CC; Tsai MK
    J Formos Med Assoc; 2016 Jun; 115(6):426-33. PubMed ID: 26725772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
    Fehr T; Hübel K; de Rougemont O; Abela I; Gaspert A; Güngör T; Hauri M; Helmchen B; Linsenmeier C; Müller T; Nilsson J; Riesterer O; Scandling JD; Schanz U; Cippà PE
    Front Immunol; 2022; 13():796456. PubMed ID: 35173720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesenchymal stem cell transfusion for desensitization of positive lymphocyte cross-match before kidney transplantation: outcome of 3 cases.
    Saadi G; Fadel F; El Ansary M; El-Hamid SA
    Cell Prolif; 2013 Apr; 46(2):121-6. PubMed ID: 23510466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beyond Criteria and Definitions: Outcome of a Standardized Antibody-Mediated Rejection Protocol with a Diagnostic Schema Different from the Banff 2009 Criteria.
    Rendulic T; Ramon DS; Killen PD; Samaniego-Picota M; Park JM
    Clin Transpl; 2014; ():179-87. PubMed ID: 26281143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of tandem hemodialysis and immunoadsorption to desensitize kidney transplant candidates.
    Rostaing L; Maggioni S; Hecht C; Hermelin M; Faudel E; Kamar N; Sallusto F; Doumerc N; Allal A
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():165-9. PubMed ID: 25894148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.